ADMA Biologics, Inc. (ADMA)
13.24
+0.05
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
13.45
+0.21
(+1.59%)
After-Hours: 20:00
ADMA Biologics Market Cap : 2.950B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.950B |
| November 11, 2026 | 2.939B |
| November 10, 2026 | 2.823B |
| November 09, 2026 | 2.850B |
| November 06, 2026 | 2.836B |
| November 05, 2026 | 2.943B |
| November 04, 2026 | 2.335B |
| November 03, 2026 | 2.475B |
| November 02, 2026 | 2.464B |
| October 30, 2026 | 2.571B |
| October 29, 2026 | 2.648B |
| October 28, 2026 | 2.542B |
| October 27, 2026 | 2.517B |
| October 26, 2026 | 2.494B |
| October 23, 2026 | 2.407B |
| October 22, 2026 | 2.468B |
| October 21, 2026 | 2.481B |
| October 20, 2026 | 2.531B |
| October 19, 2026 | 2.495B |
| October 16, 2026 | 2.407B |
| October 15, 2026 | 2.418B |
| October 14, 2026 | 2.330B |
| October 13, 2026 | 2.323B |
| October 12, 2026 | 2.294B |
| October 09, 2026 | 2.335B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.328B |
| October 07, 2026 | 2.285B |
| October 06, 2026 | 2.294B |
| October 05, 2026 | 2.278B |
| October 02, 2026 | 2.190B |
| October 01, 2026 | 2.238B |
| September 30, 2026 | 2.260B |
| September 29, 2026 | 2.245B |
| September 28, 2026 | 2.281B |
| September 25, 2026 | 2.114B |
| September 24, 2026 | 2.145B |
| September 23, 2026 | 2.186B |
| September 22, 2026 | 2.211B |
| September 21, 2026 | 2.142B |
| September 18, 2026 | 2.053B |
| September 17, 2026 | 2.017B |
| September 16, 2026 | 2.006B |
| September 15, 2026 | 1.940B |
| September 14, 2026 | 2.060B |
| September 11, 2026 | 2.080B |
| September 10, 2026 | 2.116B |
| September 09, 2026 | 2.130B |
| September 08, 2026 | 2.150B |
| September 04, 2026 | 2.168B |
| September 03, 2026 | 2.159B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| BioMarin Pharmaceutical, Inc. | 10.98B |
| Nektar Therapeutics | 1.271B |
| Rhythm Pharmaceuticals, Inc. | 7.615B |
| Arcutis Biotherapeutics, Inc. | 3.469B |
Market Cap Related Metrics
| PE Ratio | 17.05 |
| PS Ratio | 5.993 |
| Price to Book Value | 6.727 |
| Price to Free Cash Flow | 23.46 |
| Price | 13.24 |
| Earnings Yield | 5.86% |
| Operating PE Ratio | 13.34 |
| Normalized PE Ratio | 17.05 |